E-PRESCRIBING WOULD BOOST GENERIC DRUG USE, PCMA CONTENDS

Published Online: Monday, October 1, 2007

Widespread use of electronic prescribing (e-prescribing) for Medicare drug patients would reduce the cost of the program's Part D prescription benefit by significantly increasing the use of cheaper generic pharmaceuticals, representatives of the nation's pharmacy benefit managers said. "Requiring eprescribing in Medicare would improve medication adherence by alerting physicians and patients when clinically sound, yet more affordable, drugs are available to treat specific conditions," the Pharmaceutical Care Management Association (PCMA) said. "Currently, neither seniors nor their doctors are aware of their full range of pharmacy options, including generic drugs," the group said.

In addition to boosting generic drug usage, PCMA maintained that e-prescribing could prevent up to 1.9 million medication errors-a result that could save Medicare beneficiaries and the federal government billions of dollars over the next decade. The increased use of generics and other "existing proven pharmacy benefit management tools?are generating savings on average of 29%, compared to retail purchases with no pharmacy benefit management support," the group said.



Latest Articles
Health-system pharmacists can play a critical role in managing drug shortages to prevent medical errors and adverse events.
The White House is asking Congress for more than $1.8 billion in emergency funding to combat the Zika virus, which is creeping into the United States and ravaging some foreign countries.
Vertex Pharmaceuticals has received a complete response letter from the FDA for its supplemental new drug application for ivacaftor.
As the only pharmacist serving in Congress, US Representative Earl L. “Buddy” Carter is a critical leader of efforts to pass federal legislation pertinent to pharmacists.
Latest Issues
$auto_registration$
VSEO N/A